Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Lühr Hansen

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Trials|April 4, 2024
Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-IIIMaria Linander Vestager, Mathias Lühr Hansen, Gorm Greisen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 11, 2021
The impact of the COVID pandemic on prematurity rates: Conflicting results, publication ethics and academic frustrationGorm Greisen, Lina Chalak, Mathias Lühr Hansen, et al.
Trials|October 24, 2024
Web-based training and certification of clinical staff during the randomised clinical trial SafeBoosC-IIIMarie Isabel Skov Rasmussen, Mathias Lühr Hansen, Colin Peters, et al.
Advances in Experimental Medicine and Biology|May 9, 2021
Not Removing the Glossy White Cover from Adhesive INVOS Neonatal Sensors Affects the Oxygenation MeasurementMathias Lühr Hansen, Daniel Ostojic, Stefan Kleiser, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 22, 2018
Staging of necrotising enterocolitis by Bell's criteria is supported by a statistical pattern analysis of clinical and radiological variablesSandra Meinich Juhl, Mathias Lühr Hansen, Magdalena Gormsen, et al.
Plos One|April 12, 2019
Behavioural and neurodevelopmental impairment at school age following necrotising enterocolitis in the newborn periodMathias Lühr Hansen, Ida Voss Jensen, Rasmus Gregersen, et al.
BMC Medical Research Methodology|August 1, 2021
Central data monitoring in the multicentre randomised SafeBoosC-III trial - a pragmatic approachMarkus Harboe Olsen, Mathias Lühr Hansen, Sanam Safi, et al.
BMC Medical Research Methodology|June 25, 2026
Optimising data completeness and quality in multicentre randomised clinical trials using central data monitoring: a pragmatic approachMarkus Harboe Olsen, Mathias Lühr Hansen, Janus Engstrøm, et al.
Frontiers in Pediatrics|February 21, 2022
Cerebral Oximetry in Preterm Infants-To Use or Not to Use, That Is the QuestionGorm Greisen, Mathias Lühr Hansen, Marie Isabel Skov Rasmussen, et al.
Trials|November 17, 2023
Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infantsMarkus Harboe Olsen, Mathias Lühr Hansen, Theis Lange, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Trials|April 4, 2024
Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-IIIMaria Linander Vestager, Mathias Lühr Hansen, Gorm Greisen, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 11, 2021
The impact of the COVID pandemic on prematurity rates: Conflicting results, publication ethics and academic frustrationGorm Greisen, Lina Chalak, Mathias Lühr Hansen, et al.
Trials|October 24, 2024
Web-based training and certification of clinical staff during the randomised clinical trial SafeBoosC-IIIMarie Isabel Skov Rasmussen, Mathias Lühr Hansen, Colin Peters, et al.
Advances in Experimental Medicine and Biology|May 9, 2021
Not Removing the Glossy White Cover from Adhesive INVOS Neonatal Sensors Affects the Oxygenation MeasurementMathias Lühr Hansen, Daniel Ostojic, Stefan Kleiser, et al.
Acta Paediatrica (Oslo, Norway : 1992)|June 22, 2018
Staging of necrotising enterocolitis by Bell's criteria is supported by a statistical pattern analysis of clinical and radiological variablesSandra Meinich Juhl, Mathias Lühr Hansen, Magdalena Gormsen, et al.
Plos One|April 12, 2019
Behavioural and neurodevelopmental impairment at school age following necrotising enterocolitis in the newborn periodMathias Lühr Hansen, Ida Voss Jensen, Rasmus Gregersen, et al.
BMC Medical Research Methodology|August 1, 2021
Central data monitoring in the multicentre randomised SafeBoosC-III trial - a pragmatic approachMarkus Harboe Olsen, Mathias Lühr Hansen, Sanam Safi, et al.
BMC Medical Research Methodology|June 25, 2026
Optimising data completeness and quality in multicentre randomised clinical trials using central data monitoring: a pragmatic approachMarkus Harboe Olsen, Mathias Lühr Hansen, Janus Engstrøm, et al.
Frontiers in Pediatrics|February 21, 2022
Cerebral Oximetry in Preterm Infants-To Use or Not to Use, That Is the QuestionGorm Greisen, Mathias Lühr Hansen, Marie Isabel Skov Rasmussen, et al.
Trials|November 17, 2023
Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infantsMarkus Harboe Olsen, Mathias Lühr Hansen, Theis Lange, et al.
Pageof 3